461 related articles for article (PubMed ID: 19903431)
1. [Pyoderma gangrenosum--clinical, laboratory and therapeutic approaches. Review of 28 cases].
Duarte AF; Nogueira A; Lisboa C; Azevedo F
Dermatol Online J; 2009 Jul; 15(7):3. PubMed ID: 19903431
[TBL] [Abstract][Full Text] [Related]
2. [Pyoderma gangrenosum: a report of 15 cases and review of the literature].
Suárez-Pérez JA; Herrera-Acosta E; López-Navarro N; Vilchez-Márquez F; Prieto JD; Bosch RJ; Herrera E
Actas Dermosifiliogr; 2012 Mar; 103(2):120-6. PubMed ID: 21782147
[TBL] [Abstract][Full Text] [Related]
3. Review of 26 cases of classical pyoderma gangrenosum: clinical and therapeutic features.
Vidal D; Puig L; Gilaberte M; Alomar A
J Dermatolog Treat; 2004 Jun; 15(3):146-52. PubMed ID: 15204146
[TBL] [Abstract][Full Text] [Related]
4. [Pyoderma gangrenosum. 15 cases].
Riahi I; Mokni M; Haouet S; Cherif F; El Euch D; Azaiz MI; Zitouna MM; Ben Osman-Dhahri A
Ann Med Interne (Paris); 2001 Feb; 152(1):3-9. PubMed ID: 11240419
[TBL] [Abstract][Full Text] [Related]
5. [Pyoderma gangrenosum associated with hidradenitis suppurativa: a case report and review of the literature].
García-Rabasco AE; Esteve-Martínez A; Zaragoza-Ninet V; Sánchez-Carazo JL; Alegre-de-Miquel V
Actas Dermosifiliogr; 2010 Oct; 101(8):717-21. PubMed ID: 20965015
[TBL] [Abstract][Full Text] [Related]
6. Pyoderma gangrenosum requiring inpatient management: a report of 26 cases with follow up.
Saracino A; Kelly R; Liew D; Chong A
Australas J Dermatol; 2011 Aug; 52(3):218-21. PubMed ID: 21834821
[TBL] [Abstract][Full Text] [Related]
7. Neutrophilic dermatoses: a review of current treatment options.
Cohen PR
Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
[TBL] [Abstract][Full Text] [Related]
8. [An uncommon localization of pyoderma gangrenosum on the penis of an HIV infected patient in the Ivory Coast].
Ecra E; Ahogo KC; Sangaré A; Kaloga M; Kassi K; Kouamé K; Kacou DE; Gbery IP; Yoboué YP; Kanga JM
Bull Soc Pathol Exot; 2009 May; 102(2):85-7. PubMed ID: 19583026
[TBL] [Abstract][Full Text] [Related]
9. Pyoderma gangrenosum: an Indian perspective.
Bhat RM; Nandakishore B; Sequeira FF; Sukumar D; Kamath GH; Martis J; Furtado S
Clin Exp Dermatol; 2011 Apr; 36(3):242-7. PubMed ID: 21070329
[TBL] [Abstract][Full Text] [Related]
10. Disseminated superficial porokeratosis and pyoderma gangrenosum.
di Meo N; Fluehler C; Perkan V; Trevisan G
Dermatol Online J; 2010 Oct; 16(10):15. PubMed ID: 21062609
[TBL] [Abstract][Full Text] [Related]
11. Topical tacrolimus for the treatment of localized, idiopathic, newly diagnosed pyoderma gangrenosum.
Marzano AV; Trevisan V; Lazzari R; Crosti C
J Dermatolog Treat; 2010 May; 21(3):140-3. PubMed ID: 19903010
[TBL] [Abstract][Full Text] [Related]
12. Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease.
Menachem Y; Gotsman I
Isr Med Assoc J; 2004 Feb; 6(2):88-90. PubMed ID: 14986464
[TBL] [Abstract][Full Text] [Related]
13. [Cutaneous pyoderma gangrenosum with hepatosplenic localization and monoclonal gammapathy. A case report].
Delbrel X; Germain P; Fach J; Etienne G; Beylot C; Parrens M; De Mascarel A; Le Bras M; Longy-Boursier M
Ann Med Interne (Paris); 2001 Feb; 152(1):65-7. PubMed ID: 11240430
[TBL] [Abstract][Full Text] [Related]
14. [Pyoderma gangrenosum: report of 11 cases].
López de Maturana D; Amaro P; Aranibar L; Segovia L
Rev Med Chil; 2001 Sep; 129(9):1044-50. PubMed ID: 11725468
[TBL] [Abstract][Full Text] [Related]
15. Pyoderma gangrenosum: an updated review.
Ruocco E; Sangiuliano S; Gravina AG; Miranda A; Nicoletti G
J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1008-17. PubMed ID: 19470075
[TBL] [Abstract][Full Text] [Related]
16. Clinical features, causes, treatments, and outcomes of peristomal pyoderma gangrenosum (PPG) in 44 patients: The Mayo Clinic experience, 1996 through 2013.
Barbosa NS; Tolkachjov SN; El-Azhary RA; Davis MD; Camilleri MJ; McEvoy MT; Bridges AG; Wetter DA
J Am Acad Dermatol; 2016 Nov; 75(5):931-939. PubMed ID: 27473454
[TBL] [Abstract][Full Text] [Related]
17. Letter: Treatment-resistant pyoderma gangrenosum.
Kosari P; Feldman SR
Dermatol Online J; 2012 Apr; 18(4):8. PubMed ID: 22559023
[TBL] [Abstract][Full Text] [Related]
18. [Pyoderma gangrenosum: a report of 3 cases].
Ma ZL; Zhang TL
Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(21):1479-81. PubMed ID: 18275714
[TBL] [Abstract][Full Text] [Related]
19. Pyoderma gangrenosum: study of 21 patients and proposal of a 'clinicotherapeutic' classification.
Marzano AV; Trevisan V; Lazzari R; Crosti C
J Dermatolog Treat; 2011 Oct; 22(5):254-60. PubMed ID: 20666672
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease.
Zaccagna A; Bertone A; Puiatti P; Picciotto F; Sprujevnik T; Santucci R; Rossini FP
Eur J Dermatol; 2003; 13(3):258-60. PubMed ID: 12804985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
